Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: Single and multiple dosing bioavailability studies

C. L. Saccar; L. D. Green; C. L. Helsel; M. E. Niehls; J. A. Diconcetto; H. C. Mansmann; S. J. McGeady

Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: Single and multiple dosing bioavailability studies

C. L. Saccar
, L. D. Green
, C. L. Helsel
, M. E. Niehls
, J. A. Diconcetto
, H. C. Mansmann
, S. J. McGeady

Thomas Jefferson University
Unknown

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Both single and multiple dosing bioavailability studies of the two sustained-release theophylline products, Slo-bid Gyrocap® and Theo-Dur®, in healthy volunteers indicate a complete and comparable extent of absorption. Slo-bid Gyrocap® demonstrated a much slower absorption profile than Theo-Dur®.

Original language	English
Pages (from-to)	245-248
Number of pages	4
Journal	Annals of Allergy
Volume	50
Issue number	4
State	Published - 1983
Externally published	Yes

Cite this

@article{195925a6aed349809b41e75ee3f9e774,

title = "Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: Single and multiple dosing bioavailability studies",

abstract = "Both single and multiple dosing bioavailability studies of the two sustained-release theophylline products, Slo-bid Gyrocap{\textregistered} and Theo-Dur{\textregistered}, in healthy volunteers indicate a complete and comparable extent of absorption. Slo-bid Gyrocap{\textregistered} demonstrated a much slower absorption profile than Theo-Dur{\textregistered}.",

author = "Saccar, \{C. L.\} and Green, \{L. D.\} and Helsel, \{C. L.\} and Niehls, \{M. E.\} and Diconcetto, \{J. A.\} and Mansmann, \{H. C.\} and McGeady, \{S. J.\}",

year = "1983",

language = "English",

volume = "50",

pages = "245--248",

journal = "Annals of Allergy",

issn = "0003-4738",

publisher = "American College of Allergy, Asthma and Immunology",

number = "4",

}

TY - JOUR

T1 - Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile

T2 - Single and multiple dosing bioavailability studies

AU - Saccar, C. L.

AU - Green, L. D.

AU - Helsel, C. L.

AU - Niehls, M. E.

AU - Diconcetto, J. A.

AU - Mansmann, H. C.

AU - McGeady, S. J.

PY - 1983

Y1 - 1983

N2 - Both single and multiple dosing bioavailability studies of the two sustained-release theophylline products, Slo-bid Gyrocap® and Theo-Dur®, in healthy volunteers indicate a complete and comparable extent of absorption. Slo-bid Gyrocap® demonstrated a much slower absorption profile than Theo-Dur®.

AB - Both single and multiple dosing bioavailability studies of the two sustained-release theophylline products, Slo-bid Gyrocap® and Theo-Dur®, in healthy volunteers indicate a complete and comparable extent of absorption. Slo-bid Gyrocap® demonstrated a much slower absorption profile than Theo-Dur®.

UR - https://www.scopus.com/pages/publications/0020540296

M3 - Article

C2 - 6340563

AN - SCOPUS:0020540296

SN - 0003-4738

VL - 50

SP - 245

EP - 248

JO - Annals of Allergy

JF - Annals of Allergy

IS - 4

ER -

Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: Single and multiple dosing bioavailability studies

Abstract

Other files and links

Fingerprint

Cite this